<?xml version="1.0" encoding="UTF-8"?>
<p>We look for a mathematical expression, which allows us to estimate this optimal dose reduction for each patient in terms of the model parameters. Although there is a minimal required plasma concentration for TKI cytotoxicity, which sets a lower limit to the dose de-escalation, a linear dose-response relationship is generally accepted over a wide range of treatment-relevant doses above this threshold.
 <sup>
  <xref rid="b25-1031825" ref-type="bibr">25</xref>,
  <xref rid="b26-1031825" ref-type="bibr">26</xref>
 </sup> Thus, we deduced an explicit expression for the patient-specific optimal favorable dose reduction fraction 
 <italic>f
  <sub>OPT</sub>
 </italic> (
 <italic>Online Supplementary Text S8</italic>), given by 
 <disp-formula id="fd5-1031825">
  <math id="mm8">
   <mrow>
    <msub>
     <mi>f</mi>
     <mrow>
      <mi>O</mi>
      <mi>P</mi>
      <mi>T</mi>
     </mrow>
    </msub>
    <mo>=</mo>
    <mfrac>
     <mrow>
      <msub>
       <mi>p</mi>
       <mi>Y</mi>
      </msub>
      <mo>+</mo>
      <mn>2</mn>
      <msub>
       <mi>p</mi>
       <mrow>
        <mi>X</mi>
        <mi>Y</mi>
       </mrow>
      </msub>
     </mrow>
     <mrow>
      <msub>
       <mi>p</mi>
       <mi>Y</mi>
      </msub>
      <mo>+</mo>
      <mi>q</mi>
     </mrow>
    </mfrac>
   </mrow>
  </math>
  <label>(E5)</label>
 </disp-formula>
</p>
